| DC Field | Value | Language |
|---|
| dc.contributor.author | Korokina, L. V. | - |
| dc.contributor.author | Pokrovskii, M. V. | - |
| dc.contributor.author | Kochkarova, I. S. | - |
| dc.contributor.author | Pokopeiko, O. N. | - |
| dc.contributor.author | Povetkin, S. V. | - |
| dc.date.accessioned | 2023-03-02T13:50:30Z | - |
| dc.date.available | 2023-03-02T13:50:30Z | - |
| dc.date.issued | 2021 | - |
| dc.identifier.citation | Investigation of allergenic and mutagenic effects of phenolic compound, an arignase-2 inhibitor / L.V. Korokina [et al.] // Journal of Medicinal and Chemical Sciences. - 2021. - Vol.4.-P. 301-307. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/51991 | - |
| dc.description.abstract | A big risk factor for sensitization and allergic diseases is susceptibility to animal allergens. The most significant animal allergens are derived from mammals, besides mites and cockroaches. The experiments on the allergenic properties of KUD975 were carried out on bisexual sexually mature albino guinea pigs weighing 300 ± 20 g. During the initial assessment of allergenic and mutagenic properties, the allergenic properties of KUD975 were studied by setting up an active skin anaphylaxis reaction | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | endothelial disfunction | ru |
| dc.subject | arginase2 | ru |
| dc.subject | thrombin | ru |
| dc.subject | arterial hypertension | ru |
| dc.subject | allergenicity | ru |
| dc.subject | mutagenicity | ru |
| dc.subject | phenolic compound | ru |
| dc.title | Investigation of allergenic and mutagenic effects of phenolic compound, an arignase-2 inhibitor | ru |
| dc.type | Article | ru |
| Appears in Collections: | Статьи из периодических изданий и сборников (на иностранных языках) = Articles from periodicals and collections (in foreign languages)
|
